Published Data Registry

show all
TitleAuthorsJournal ▾Publication year
DOI
PMID
Human induced pluripotent stem cells for live cell cycle monitoring and endogenous gene activation(Open Access) Kim R, Nagel SH, Liaw NY, Zimmermann W, Zelarayán LC, Schoger EStem Cell Research2024
Generation of Pelizaeus-Merzbacher disease (PMD) mutant (PLP1-C33Y) in induced pluripotent stem cell (iPSC) by CRISPR/Cas9 genome editing(Open Access) Schreiber M, Zafeiriou MStem Cell Research2023
Generation of a fluorescent oligodendrocyte reporter line in human induced pluripotent stem cells(Open Access) Schreiber M, Zafeiriou MStem Cell Research2023
Genome engineering of a neuronal specific, optogenetic, induced pluripotent stem cell line(Open Access) Schmoll AK, Mager T, Tse TP, Alameldeen A, Zimmermann W, Zafeiriou MStem Cell Research2024
Establishment of two homozygous CRISPR interference (CRISPRi) knock-in human induced pluripotent stem cell (hiPSC) lines for titratable endogenous gene repression(Open Access) Schoger E, Zimmermann W, Cyganek L, Zelarayán LCStem Cell Research2021
Establishment of a second generation homozygous CRISPRa human induced pluripotent stem cell (hiPSC) line for enhanced levels of endogenous gene activation(Open Access) Schoger E, Zimmermann W, Cyganek L, Zelarayán LCStem Cell Research2021
Generation of a genetically-modified induced pluripotent stem cell line harboring an oncogenic gene variant KRAS p.G12V(Open Access) Busley AV, Kleinsorge M, Cyganek LStem Cell Research2023
Generation of a genetically-modified induced pluripotent stem cell line harboring a Noonan syndrome-associated gene variant MRAS p.G23V(Open Access) Busley AV, Cyganek LStem Cell Research2023
Generation of a pluripotent stem cell line (UMGi270-A) and a corresponding CRISPR/Cas9 modified isogenic control (UMGi270-A-1) from a patient with sudden onset dilated cardiomyopathy harboring a FLNC p.R2187P mutation(Open Access) Maurer W, Rebs S, (...), Streckfuss-Bömeke KStem Cell Research2024
Combining a Tetracycline (Tet)-inducible gRNA system and CRISPRa for titratable and timely controlled enhancement of endogenous SHISA3 activation in human induced pluripotent stem cells (hiPSC)(Open Access) Priesmeier L, Schoger E, Cyganek L, Cecilia Zelarayán LStem Cell Research2023